Cardeon Futuring Finance continues to expand the company’s management through four new Senior Partners.
Professor of Physics at Lund University up until 2016. Since 2016 Director of Biophotonics at Tyndall National Institute, Ireland. Postdoc at McMasters University in Hamilton, Ontario, Canada. Received the Erna Ebelings award, Swedish Society for Medical Technology and Physics, 2003. Co-author of more than 200 published peer-reviewed articles.
Bachelor of Science in Chemistry and Biology, Doctor of Physiology from Uppsala University, and Associate Professor at Uppsala University. Consultant in biotechnology and finance. Previously worked on research and business development at both Astra AB and Pharmacia AB. Thereafter, as a pharmaceutical analyst in the financial industry, such as at Swedbank, Aros Securities and ABG Sundal Collier. Today, the Chairman of the Board of, among others, Miris Holding, SpectraCure and EQL Pharma.
Professor of Surgery at Lund University since 2000. Solid clinical experience, and clinical and translational research. Author of more than 500 published peer-reviewed articles. Supervisor for some 30 PhD graduate students in the areas of cancer, systemic inflammation, organ failure and bowel function.
Medical candidate from Karolinska Institutet, MBA from Stockholm School of Economics. Currently a partner at Rewell Medical AB. Previously been General Manager, Vice President of EMEA at Hycor Biomedical, Vice President Commercial Operations Europe at Thermo Fisher Scientific Immuno Diagnostics Division.